Lucid Diagnostics (LUCD) Payables (2020 - 2026)

Lucid Diagnostics (LUCD) has 7 years of Payables data on file, last reported at $26.3 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 24.65% year-over-year to $26.3 million; the trailing twelve-month figure through Mar 2026 stood at $26.3 million (down 24.65% YoY), and the FY2025 full-year result was $25.0 million, up 25.85% from the prior year.
• Payables for Q1 2026 stood at $26.3 million, up from $25.0 million in the prior quarter.
• Across five years, Payables topped out at $34.9 million in Q1 2025 and bottomed at $1.1 million in Q3 2022.
• The 5-year median for Payables is $15.5 million (2023), against an average of $16.1 million.
• The widest annual swing landed in 2023, when Payables surged 1509.47%; it then decreased 24.65% in 2026.
• A 5-year view of Payables shows it stood at $1.4 million in 2022, then soared by 1509.47% to $23.3 million in 2023, then retreated by 14.81% to $19.8 million in 2024, then climbed by 25.85% to $25.0 million in 2025, then grew by 5.23% to $26.3 million in 2026.
• The last three Payables figures came in at $26.3 million (Q1 2026), $25.0 million (Q4 2025), and $23.1 million (Q3 2025), per Business Quant data.

Peer Comparison